Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Hemophilia A
Recent news which mentions Hemophilia A
Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
March 09, 2022
Tickers
BIOVF
SNY
Tags
Phase 3 Results
Benzinga
Movers
From
Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
Briefs
BMRN
News
From
Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
December 14, 2021
Tickers
SNY
Tags
Briefs
Phase 3 Trial
Benzinga
From
Benzinga
Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program
December 14, 2021
Tickers
GBIO
Tags
News
GBIO
Trading Ideas
From
Benzinga
Sigilon Therapeutics Issues An Update On Its Early-Stage Hemophilia Study
November 29, 2021
Tickers
SGTX
Tags
Phase 2 Trial
General
SGTX
From
Benzinga
Centessa Stock Surges On Positive Data From Hemophilia Candidate
September 09, 2021
Tickers
CNTA
Tags
Benzinga
Hemophilia
Movers
From
Benzinga
BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy
July 21, 2021
Tickers
BMRN
Tags
Market News
Hemophilia A
Health Care
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Achieve Stable, Durable FVIII Expression
July 21, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
gene therapy
From
Benzinga
Roche Unveils New Hemlibra Data Reinforcing Safety Profile In Hemophilia A
July 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
Benzinga
Biotech
From
Benzinga
BioMarin Expects EMA's CHMP Opinion In 1H 2022 For Its Hemophilia A Gene Therapy, FDA Resubmission In 2Q'22
July 15, 2021
Tickers
BMRN
Tags
News
Briefs
BMRN
From
Benzinga
Serious Adverse Event Triggers FDA Clinical Hold On Sigilon Therapeutics' Hemophilia A Trial, Shares Drop
July 09, 2021
Tickers
SGTX
Tags
Hemophilia A
Biotech
Health Care
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.